-1775582746855.png&w=3840&q=75)
Pay in 4 interest-free payments of $6.66 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
As the use of glucagon-like peptide-1 receptor agonists (GLP-1) medications explodes, retail insurance agents need to be aware of the emerging exposures associated with them
1 , CD009461 (2013)
The study results shown above reflect group averages after 72 weeks
Its binding profile is deliberately imbalanced, showing strong affinity for the GIP receptor with an EC50 of 22.4 pM while demonstrating roughly five times weaker GLP-1 receptor activation compared to native GLP-1, with an EC50 of 934 pM versus 70.5 pM for the endogenous hormone
US$ 20.86
:max_bytes(150000):strip_icc()/VWH-GettyImages-2275860768-a6f6e63304e048d0a829844c1dacbd8d.jpg)
US$ 20.70
US$ 23.05
